Tacrolimus and Ultomiris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Ultomiris (ravulizumab-cwvz). Common drug interactions include pseudomembranous colitis among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Ultomiris. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Ultomiris?

Ultomiris has active ingredients of ravulizumab-cwvz. eHealthMe is studying from 5,775 Ultomiris users. Check the latest studies of Ultomiris.



On Jul, 08, 2026

28 people who take Tacrolimus and Ultomiris together, and have interactions are studied.

Tacrolimus and Ultomiris drug interactions.

What are the common drug interactions of Tacrolimus and Ultomiris, by gender? *:

female:

  1. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
  2. Platelet count decreased
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Hip arthroplasty
  5. Nausea (feeling of having an urge to vomit)
  6. Peripheral swelling
  7. Pyrexia (fever)
  8. Urinary tract infection
  9. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  10. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)

male:

  1. Headache (pain in head)
  2. Fatigue (feeling of tiredness)
  3. Visual impairment
  4. Renal impairment (severely reduced kidney function)
  5. Weight decreased
  6. Arthralgia (joint pain)
  7. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  8. Balance disorder
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

What are the common drug interactions of Tacrolimus and Ultomiris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Haematoma (collection of blood outside the blood vessels)
  3. Haemoglobin decreased
  4. Hypotension (abnormally low blood pressure)
  5. Polyuria (production of too much dilute urine)
  6. Renal cell carcinoma (a kidney cancer)
  7. Renal impairment (severely reduced kidney function)
  8. Anaemia (lack of blood)
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Hyperglycaemia (high blood sugar)

40-49:

  1. Headache (pain in head)
  2. Arthralgia (joint pain)
  3. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Cough
  7. Diplopia (double vision)
  8. Dizziness
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

50-59:

n/a

60+:

  1. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  2. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  3. Myasthenia gravis crisis (a paralysis of the respiratory muscles occurs)
  4. Body temperature increased
  5. Cardiac arrest
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Infection
  9. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 9 people, 32.14%
  2. Secondary Hypertension (elevated blood pressure that results from an underlying, identifiable, often correctable cause): 3 people, 10.71%
  3. Renovascular Hypertension (a syndrome which consists of high blood pressure caused by the kidneys hormonal response): 3 people, 10.71%
  4. Iron Deficiency: 3 people, 10.71%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  6. Oedema (fluid collection in tissue): 2 people, 7.14%
  7. Mycobacterium Chelonae Infection (bacterial infection): 2 people, 7.14%
  8. Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 7.14%
  9. High Blood Pressure: 2 people, 7.14%
  10. Headache (pain in head): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Ultomiris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tacrolimus and Ultomiris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultomiris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultomiris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and ravulizumab-cwvz (the active ingredients of Tacrolimus and Ultomiris, respectively), and Tacrolimus and Ultomiris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: